Back to Agenda
Session 9 Track A: Globalization of Medical Communications and Contact Center – What Can We Learn from Orphan Drug, Rare Disease, and Specialty Company Experiences
Session Chair(s)
Michael Burman, PHARMD, RPH
Head of US Customer Care, Zoetis, United States
Globalization of medical communications, from content to contact, continues to be a focus for many companies. Case studies will be highlighted from orphan drug, rare disease, and specialty companies to understand their motives, their approach, and most importantly, to identify what we can learn from their experience. Are there best practices and challenges associated with globalization that transcend company size? This session will include time for discussion and participation.
Learning Objective : At the conclusion of this session, participants should be able to:- Evaluate reasons and different models for globalizing medical communications
- Identify challenges faced by orphan drug/rare disease companies in globalizing their medical communication organizations
- Apply lessons learned and best practices from orphan drug/rare disease companies to any size or type of company
Speaker(s)
Kristen Morris, MSC
, United States
Nancy Dougherty
Senior Director Medical Communications and Information/Medical Affairs, CSL Seqirus, United States
Have an account?